Biogen: names Martin Dubuc as CEO for France
(CercleFinance.com) - Biogen said on Friday that it has appointed Martin Dubuc as CEO for its business in France, which is becoming an increasingly important market for the US biotech firm.
The executive, who formerly worked at Pfizer and Merck, joined Biogen in 2016 as senior vice-president in charge of customer innovation and commercial excellence.
With 150 employees in the country, Biogen is heavily investing in France, where the company is currently conducting 20 clinical trials and is building a global digital platform based in Paris.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The executive, who formerly worked at Pfizer and Merck, joined Biogen in 2016 as senior vice-president in charge of customer innovation and commercial excellence.
With 150 employees in the country, Biogen is heavily investing in France, where the company is currently conducting 20 clinical trials and is building a global digital platform based in Paris.
Copyright (c) 2018 CercleFinance.com. All rights reserved.